Variables:
A data frame with 236 observations on the following 7 variables.
-
treatment
-
the treatment group, a factor with levels placebo and Progabide.
-
base
-
the number of seizures before the trial.
-
age
-
the age of the patient.
-
seizure.rate
-
the number of seizures (response variable).
-
period
-
treatment period, an ordered factor with levels 1 to 4.
-
subject
-
the patient ID, a factor with levels 1 to 59.
Details
In this clinical trial, 59 patients suffering from epilepsy were randomized to groups receiving either the anti-epileptic drug Progabide or a placebo in addition to standard chemotherapy. The numbers of seizures suffered in each of four, two-week periods were recorded for each patient along with a baseline seizure count for the 8 weeks prior to being randomized to treatment and age. The main question of interest is whether taking progabide reduced the number of epileptic seizures compared with placebo.
